Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Induced Radical Surgery in Oligometastatic Non–Small Cell Lung Cancer: A Case Report
The Oncologist · 2024
DOI: 10.1093/oncolo/oyad339 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Oncologist, 2024. Verfasst von Huaiyu Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Department, Air Force Medical Center, PLA, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Protein Kinase Inhibitors, ErbB Receptors, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wu Jieping Medical Foundation.
Abstract (Originalsprache)
Sequential regimens in patients with epidermal growth factor receptor (EGFR) mutation-positive non–small cell lung cancer (NSCLC) can overcome tyrosine kinase inhibitor (TKI) resistance and maximize clinical benefit. Patients with advanced NSCLC can achieve excellent tumor control after a period of EGFR-TKI treatment. Patients may benefit from additional local treatment, such as surgery or radiation therapy, once the tumor is under control. Here, we present a case of a patient with advanced oligometastatic NSCLC with EGFR mutations who achieved downstaging through sequential EGFR-TKI-based precision medicine allowing resection of residual disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thoracic Surgery Department, Air Force Medical Center, PLA, Beijing, People's Republic of China.
- Medical Oncology Department, Air Force Medical Center, PLA, Beijing, People's Republic of China.
- Anesthesiology Department, Air Force Medical Center, PLA, Beijing, People's Republic of China.
- The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, Jiangsu Province, People's Republic of China.
Förderung
- Wu Jieping Medical Foundation
Zitieren
APA
Wang, H., Fan, Z., Yang, X., Wu, Q., Jiang, S., Zhu, J., Liu, J., Zhou, C., Liu, Y., You, X., & Han, Y. (2024). Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Induced Radical Surgery in Oligometastatic Non–Small Cell Lung Cancer: A Case Report. The Oncologist. https://doi.org/10.1093/oncolo/oyad339
Vancouver
Wang H, Fan Z, Yang X, Wu Q, Jiang S, Zhu J, et al. Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Induced Radical Surgery in Oligometastatic Non–Small Cell Lung Cancer: A Case Report. The Oncologist. 2024. doi:10.1093/oncolo/oyad339
BibTeX
@article{Wang2024,
author = {Wang, Huaiyu and Fan, Zaiwen and Yang, Xiaoming and Wu, Qing and Jiang, Suxin and Zhu, Jingna and Liu, Jie and Zhou, Chuanhong and Liu, Yinghui and You, Xia and Han, Yong},
title = {Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Induced Radical Surgery in Oligometastatic Non–Small Cell Lung Cancer: A Case Report},
journal = {The Oncologist},
year = {2024},
doi = {10.1093/oncolo/oyad339}
}
EUVIMED